medigraphic.com
SPANISH

Revista Cubana de Medicina Militar

ISSN 1561-3046 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 2

<< Back Next >>

Rev Cub Med Mil 2016; 45 (2)

Effectiveness of the use of the Comprehensive Evaluation Record on the affected patient with diabetic foot (REIPD in spanish)

Rodríguez GD
Full text How to cite this article

Language: Spanish
References: 9
Page: 165-171
PDF size: 153.75 Kb.


Key words:

diabetic foot, Heberprot-P, amputation.

ABSTRACT

Introduction: The treatment of diabetic foot with Heberprot-P requires an increasing information input of its processes. In Cuba, so far, there is only the antecedent of Registry for Diabetic Foot Comprehensive Evaluation (REIPD), by the same authors, but it is not specific for Heberprot-P treatment. Objective: Confirm the usefulness of the Comprehensive Evaluation Record of patients treated with Heberprot-P (REIPROT). Methods: The instrument was elaborated from the following stages: search and analysis of international and national instruments, revision of the main risk factors, and formation of the structure and determination of the classification proposal. The functional relationship of the instrument was studied using the Kaiser-Meyer-Okin sampling adequacy measure, the Bartlett sphericity test and the simple linear regression model. Expert judgment was used in the last three stages. Information Input required a Model Vista Controller pattern. C # was used as programming language, Sharp Developer 4.2 as development IDE and Postgre SQL 9.2 as database manager. Results: The performed parametric tests found impossible to perform a reduction of variables. In Wilcoxon test, Z values were obtained close to -7, with high degree of significance. Pearson correlation index and the coefficient of determination in relation to the total value with Heberprot-P dose and the surgical intervention were considered satisfactory, especially the latter, which showed a favorable correlation between the value of the instrument and the amputation risk. Conclusion: The integration of REIPROT into the Comprehensive Care Program for Patients with Diabetic Foot Ulcer (PAIPUPD) should favor the efficacy of the diabetic foot diagnosis and treatment process with Heberprot-P, thus reducing the risk of amputation.


REFERENCES

  1. Singhan Krishnan. Reduction in diabetic amputations over 11 years in a defined U.K. population. Diabetes Care. 2008;31:99-101.

  2. American Diabetes Association. Standards of medical care in diabetes 2012. Diabetes Care. 2012 [cited 2013 Apr 24];35(1):11-63. Available from: http://care.diabetesjournals.org/content/35/Supplement_1/S11.full.pdf+html

  3. González de la Torre H, Perdomo Pérez E, Quintana L, Mosquera Fernández A. Estratificación del riesgo en Pie Diabético. Gerocomos. 2010 [citado 13 sep 2013];21(4):172-82. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S113428X2010000400006

  4. Soldevilla JJ. Presentación del documento nacional de consenso sobre úlceras de la extremidad inferior (CONUEI): La historia continua. Anal Patol Vasc. 2009 [citado 10 sep 2011];3(1):37-45. Disponible en: http://www.nexusmedica.com/web/sumario_anteriores.php?Ano=2009&Numero=1 &id_revista=668&fano=2009&fnumero=1&ffemede=&sol=1

  5. International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot & Practical Guidelines on the Management and Prevention of the Diabetic Foot 2007 [CD-ROM]. Ámsterdam: Consultative Section of the IDF (International Diabetes Federation); 2007.

  6. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetol. 2008 [cited 13 sept 2013 ];51(5):747-55. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292424

  7. American Diabetes Association. Standards of medical care in diabetes 2012. Diabetes Care. 2012 [cited 24 apr 2013];35(1):11-63. Available from: http://care.diabetesjournals.org/content/35/Supplement_1/S11.full.pdf+html

  8. Flack S, Apelqvist J, Keith M, Trueman P, Williams D. An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers. J Wound Care. 2008 [cited 13 sept 2013 ];17(2):71-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18389832

  9. American Diabetes Association. Standards of medical care in diabetes 2012. Diabetes Care. 2012 [cited 24 apr 2013];35(1):11-63. Available from: http://care.diabetesjournals.org/content/35/Supplement_1/S11.full.pdf+html




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Med Mil . 2016;45